Curaleaf Reports 4% Sequential Revenue Growth, Exits Hemp and Missouri Markets
Event summary
- Curaleaf expects Q4 2025 net revenue of $330M, up 4% sequentially and 1% YoY, excluding discontinued businesses.
- Adjusted gross profit margin for Q4 2025 anticipated at 48.5%, matching Q4 2024 levels.
- Company to discontinue hemp division and exit Missouri market due to regulatory changes and sub-scale presence.
- Full-year 2025 adjusted gross margin expected at 50%, reflecting sustained profitability.
- Curaleaf plans to refinance senior secured notes due December 2026 as part of capital allocation strategy.
The big picture
Curaleaf's preliminary Q4 2025 results highlight the company's strategic pivot back to core cannabis operations, following the exit from hemp and Missouri. The move reflects broader industry consolidation trends and regulatory pressures shaping the cannabis sector. With sustained margins and a focus on refinancing debt, Curaleaf aims to strengthen its balance sheet amid competitive market dynamics.
What we're watching
- Regulatory Impact
- How federal THC regulations will affect Curaleaf's product mix and market positioning.
- Market Focus
- Whether Curaleaf can sustain growth by concentrating on core markets after exiting Missouri.
- Financial Strategy
- The pace at which Curaleaf completes refinancing of its senior secured notes and its impact on liquidity.
Related topics